Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation

Details for Australian Patent Application No. 2003279236 (hide)

International Classifications

Event Publications

26 February 2004 Complete Application Filed

Priority application(s): 60/390,457 21.06.02 US

4 March 2004 Application Open to Public Inspection

Published as AU-B-2003279236

22 January 2009 Application Accepted

Published as AU-B-2003279236

19 February 2009 Corrigenda

Applications Accepted - Name Index Under the name University of Pittsburgh of the Commonwealth System of High Education and Beth Israel Deaconess Medical Center, Inc., Application No. 2003279236, under INID(71), correct the co-applicant name to University of Pittsburgh of the Commonwealth System of Higher Education

30 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

Application withdrawn under section 141(1). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.